Literature DB >> 20193248

Arthroscopic treatment for osteochondral lesions of the talus: analysis of outcome predictors.

Qin-wei Guo1, Yue-lin Hu, Chen Jiao, Chang-long Yu, Ying-fang Ao.   

Abstract

BACKGROUND: Compared with traditional arthrotomy procedures, arthroscopic treatment for osteochondral lesions of the talus has some advantages. However, there has been considerable debate about the outcome predictors for this surgical technique. This study aimed to investigate the outcomes of arthroscopic treatment for osteochondral lesions of the talus, and analyze its outcome predictors.
METHODS: Clinical data of 48 patients with osteochondral lesions of the talus who underwent ankle arthroscopy were studied. Arthroscopic debridement was performed on all patients, and microfracture was also performed in 36 cases. Scores on a subjective satisfaction questionnaire, visual analog scale (VAS) for pain, and the American Orthopedic Foot & Ankle Society (AOFAS) ankle and hindfoot scores were obtained before and after surgery.
RESULTS: Five patients lost to follow up. The other forty-three patients, 8 of whom were athletes, were followed up for an average of 23.9 months. The average AOFAS post-operative score was 90.16 +/- 9.96, compared with 70.81 +/- 6.96 before surgery (t = 9.353, P < 0.001). The VAS pain score after the operation (2.51 +/- 2.45) was significantly lower than that before the operation (6.95 +/- 1.40) (t = 8.647, P < 0.001). Of the 43 patients, 35 (81.4%) had good or excellent results. There was no significant difference in outcome between the medial and lateral groups (z = 0.205, P = 0.838), while a better outcome was found with lesions smaller than 10 mm than those with larger lesions (z = 2.199, P = 0.028). Age, sex, athletic profession and location of the lesion did not significantly correlate with outcomes.
CONCLUSIONS: Arthroscopic treatment is effective and safe for osteochondral lesions of the talus. A strong correlation was found between the size of the lesion and successful outcome.

Entities:  

Mesh:

Year:  2010        PMID: 20193248

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

1.  Treatment of osteochondral lesions of the talus with microfracture technique and postoperative hyaluronan injection.

Authors:  M N Doral; O Bilge; G Batmaz; G Donmez; E Turhan; M Demirel; O A Atay; A Uzumcugil; K Atesok; D Kaya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-12-29       Impact factor: 4.342

2.  Endoscopic treatment of posterior ankle pain.

Authors:  Tahir Ogut; Egemen Ayhan; Kaan Irgit; Abdullah Ilker Sarikaya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-02-11       Impact factor: 4.342

Review 3.  Management of Posttraumatic Ankle Arthritis: Literature Review.

Authors:  Samuel O Ewalefo; Malcolm Dombrowski; Takashi Hirase; Jorge L Rocha; Mitchell Weaver; Alex Kline; Dwayne Carney; MaCalus V Hogan
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

4.  Both Magnetic Resonance Imaging and Computed Tomography Are Reliable and Valid in Evaluating Cystic Osteochondral Lesions of the Talus.

Authors:  En Deng; Lixiang Gao; Weili Shi; Xing Xie; Yanfang Jiang; Huishu Yuan; Qinwei Guo
Journal:  Orthop J Sports Med       Date:  2020-09-17

Review 5.  Rehabilitation and return-to-sports activity after debridement and bone marrow stimulation of osteochondral talar defects.

Authors:  Inge C M van Eekeren; Mikel L Reilingh; C Niek van Dijk
Journal:  Sports Med       Date:  2012-10-01       Impact factor: 11.136

6.  The Treatment of Osteochondral Lesions of the Talus with Autologous Osteochondral Transplantation and Bone Marrow Aspirate Concentrate: Surgical Technique.

Authors:  John G Kennedy; Christopher D Murawski
Journal:  Cartilage       Date:  2011-10       Impact factor: 4.634

7.  ARTHROSCOPIC TREATMENT OF OSTEOCHONDRAL LESIONS OF THE TALUS.

Authors:  Mariana Korbage de Araujo; Mario Sergio Paulillo de Cillo; Cinthia Kelly Bittar; José Luis Amin Zabeu; Caroliny Nociti Moreira Cezar
Journal:  Acta Ortop Bras       Date:  2016 Jan-Feb       Impact factor: 0.513

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.